Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Top questions on the minds of QPPV

Posted on December 21st, 2016 by in Pharmacovigilance

The 2016 Pharmacovigilance Days (PHV Day 2016) kicked off in early April 2016 in Berlin, Germany. Afterwards, the tour continued to Amsterdam, London, Copenhagen, Rome and Paris in October and November. With the objective of bringing together safety experts from the pharmaceutical and healthcare industry Continue reading “Top questions on the minds of QPPV” »

How Pharma Will Be Impacted by Trump’s Healthcare Reform Plans

Posted on November 25th, 2016 by in Pharma R&D

It has only been a couple of days since Donald Trump was elected President of the United States, but the pharmaceutical and biotech industries are already wondering what might be in store for them in 2017. Continue reading “How Pharma Will Be Impacted by Trump’s Healthcare Reform Plans” »

Start-up Spotlight: Proteios

Posted on November 11th, 2016 by in Pharma R&D

This week’s Start-Up Spotlight, featuring start-ups in the pharmaceutical and biotech spaces, is showcasing the Seattle-based firm Proteios. Dr. Bob Snyder, Managing Director of Proteios, discusses the company and its game-changing research. Continue reading “Start-up Spotlight: Proteios” »

The Intersection of Pharma and Tech: Digital Pharma

Posted on October 19th, 2016 by in Pharma R&D

For years, the pharmaceutical or biopharma industry and the information technology (IT) sector seemed to be more or less separate entities. This has certainly changed in more recent times. Continue reading “The Intersection of Pharma and Tech: Digital Pharma” »

  1. 1
  2. 2